Weighted Average Number of Shares Outstanding, Diluted of Inari Medical, Inc. from 31 Dec 2018 to 30 Sep 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Inari Medical, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Dec 2018 to 30 Sep 2024.
  • Inari Medical, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2024 was 58,366,364, a 0.38% decline year-over-year.
  • Inari Medical, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 56,770,657, a 7.4% increase from 2022.
  • Inari Medical, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 52,837,674, a 5% decline from 2021.
  • Inari Medical, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 55,594,159, a 7.8% increase from 2020.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Inari Medical, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 58,366,364 -222,088 -0.38% 01 Jul 2024 30 Sep 2024 10-Q 28 Oct 2024 2024 Q3
Q2 2024 58,142,454 -353,896 -0.6% 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2024 2024 Q2
Q1 2024 57,938,115 +3,182,091 +5.8% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2024 2024 Q1
Q4 2023 56,770,657 +3,932,983 +7.4% 01 Oct 2023 31 Dec 2023 10-K 29 Feb 2024 2023 FY
Q3 2023 58,588,452 +5,096,827 +9.5% 01 Jul 2023 30 Sep 2023 10-Q 28 Oct 2024 2024 Q3
Q2 2023 58,496,350 +5,312,583 +10% 01 Apr 2023 30 Jun 2023 10-Q 30 Jul 2024 2024 Q2
Q1 2023 54,756,024 +3,801,309 +7.5% 01 Jan 2023 31 Mar 2023 10-Q 30 Apr 2024 2024 Q1
Q4 2022 52,837,674 -2,756,485 -5% 01 Oct 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 53,491,625 +3,489,629 +7% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023 2023 Q3
Q2 2022 53,183,767 -2,411,249 -4.3% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 50,954,715 -4,767,578 -8.6% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q4 2021 55,594,159 +4,039,163 +7.8% 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q3 2021 50,001,996 -5,720,297 -10% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 55,595,016 +31,299,116 +129% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 55,722,293 +10,769,589 +24% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 51,554,996 01 Oct 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
Q3 2020 55,722,293 +11,811,041 +27% 01 Jul 2020 30 Sep 2020 10-Q 04 May 2022 2022 Q1
Q2 2020 24,295,900 +18,542,568 +322% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021 2021 Q2
Q1 2020 44,952,704 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q3 2019 43,911,252 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 5,753,332 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020 2020 Q2

Inari Medical, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 56,770,657 +3,932,983 +7.4% 01 Jan 2023 31 Dec 2023 10-K 29 Feb 2024 2023 FY
2022 52,837,674 -2,756,485 -5% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
2021 55,594,159 +4,039,163 +7.8% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
2020 51,554,996 +45,667,454 +776% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
2019 5,887,542 +830,799 +16% 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022 2021 FY
2018 5,056,743 01 Jan 2018 31 Dec 2018 10-K 09 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.